Avalon GloboCare Corp. 8-K

What Happened Avalon GloboCare Corp. (ALBT) filed an 8-K on April 17, 2026 reporting that on April 15, 2026 Nasdaq notified the company it is not in compliance with the minimum $1.00 per-share bid price requirement under Nasdaq Listing Rule 5550(a)(2). The deficiency was determined based on the company’s closing bid prices from March 1, 2026 through April 14, 2026. The Nasdaq notice does not immediately affect trading; ALBT will continue trading on The Nasdaq Capital Market.

Key Details

• Nasdaq rule: Minimum bid price requirement is $1.00 per share (Nasdaq Listing Rule 5550(a)(2)); a deficiency exists if it continues for 30 consecutive business days (Rule 5810(c)(3)(A)).
• Timeline: Company has 180 calendar days (until October 12, 2026) to regain compliance by achieving a closing bid ≥ $1.00 for at least 10 consecutive business days.
• Second period/alternative cure: If eligible, Nasdaq may grant an additional 180 days provided the company meets other listing standards (market value of publicly held shares and initial listing standards) and notifies Nasdaq it will cure the deficiency, potentially via a reverse stock split.
• Next steps: If the company fails to regain compliance and is not eligible for a second period, Nasdaq may move to delist, after which Avalon would have the right to appeal to a Hearings Panel. The company said it will monitor the stock price and may consider options, including a reverse stock split.

Why It Matters A continued failure to meet the $1.00 bid price could ultimately lead to delisting from Nasdaq, which would reduce liquidity and could limit investor access to ALBT shares. The notice gives Avalon time to restore compliance (market action or corporate actions such as a reverse split); investors should watch the stock’s closing price, any corporate actions the company announces, and further Nasdaq communications.